405P Single- and repeat-dose nonclinical data for PGN-EDO51 demonstrated favorable pharmacology and safety profiles for the treatment of DMD.

Autor: Sweeney, C.1 (AUTHOR), Gilbert, J.1 (AUTHOR), Lamore, S.1 (AUTHOR), Lonkar, P.1 (AUTHOR), Foy, J.1 (AUTHOR), Holland, A.1 (AUTHOR)
Zdroj: Neuromuscular Disorders. 2024 Supplement 1, Vol. 43, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: